JMDC FY25Q2 financial review. Health Big Data business expands; 2×2 synergies?

On November 5, 2024, JMDC, Inc., the macro-composition medical data company in Japan, released its financial results for the second quarter of FY25. Here’s a detailed analysis of the key takeaways and implications